Hutch News

Hutch News

Stories tagged 'Transplant and Immunotherapy'

Poor quality of life in 1 in 5 caregivers of bone marrow transplant survivors

Largest-ever study IDs risk factors, paves way for interventions to help

June 28, 2018 | By Susan Keown / Fred Hutch News Service

Being the caregiver of a loved one with a serious illness can be a tough job — and one that's too often under the radar. In a new study, Fred Hutch researchers take a hard look at how some of these "silent supporters" are doing.

View story >


His immune system eradicated his melanoma. Could other patients’ bodies be taught to do the same thing?

How one man’s T cells are guiding the development of next-gen immunotherapies

June 19, 2018 | by Susan Keown / Fred Hutch News Service

Chris Pope's immune system eradicated his stage 4 melanoma on an immunotherapy clinical trial. Is it possible to genetically reprogram other patients' to do the same thing?

View story >


Dr. Joshua Hill receives Amy Strelzer Manasevit grant award

Award will help fund ‘paradigm shift’ in diagnosing post-transplant infections

June 6, 2018 | By Mary Engel / Fred Hutch News Service

Dr. Joshua Hill, a physician-researcher at Fred Hutch who studies post-transplant complications, has received one of the most coveted honors in the transplantation field.

View story >


Immunotherapy has long-term benefit for patients with advanced Merkel cell carcinoma

‘Incredibly big change’ in treatment of deadly skin cancer, new data show

June 4, 2018 | by Susan Keown / Fred Hutch News Service

Immunotherapy drugs have transformed the treatment of a deadly skin cancer, Merkel cell carcinoma. New trial results show these drugs help many patients survive much longer than would otherwise be possible.

View story >


Tinkering with T cells

How researchers are tweaking engineered immune cells’ cancer-targeting receptors — and why it matters

May 15, 2018 | By Susan Keown / Fred Hutch News Service

These immune cells are the cornerstone of emerging cancer therapies. And their unimaginably tiny, cancer-targeting molecular weapons — their receptors — are the focus of intense scientific tinkering.

View story >


Mariners honor cancer survivor Colin Craig

Seattle native works to support lifesaving research — like the immunotherapy that put his cancer in remission

May 3, 2018 | By Sabrina Richards / Fred Hutch News Service

Throughout the 2018 Major League Baseball season, Fred Hutch and the Seattle Mariners are recognizing “Hutch Heroes,” including lymphoma survivor Colin Craig, who works to support our lifesaving research.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.